MolMed and Megapharm enter into a license and distribution agreement for Zalmoxis® in IsraelLicense and Distribution Agreement • April 28th, 2017
Contract Type FiledApril 28th, 2017Milan (Italy), April 28, 2016 – MolMed S.p.A. (“MolMed”) and Megapharm Ltd (“Megapharm”) today announce they signed a distribution and license agreement which defines all terms and conditions for the supply, registration, promotion and distribution of Zalmoxis in Israel, as anticipated on December 1, 2016, when the companies signed a term sheet defining the main terms and conditions.